Results 181 to 190 of about 40,359 (286)

Full-house nephropathy in antinuclear antibody-negative systemic lupus erythematosus: A case report. [PDF]

Clin Case Rep
Dhungana R, Bashyal B, Paudel S, Shrestha B, Jha S, Bhurtyal N.   +5 more
europepmc   +1 more source

Antinuclear antibody-negative systemic lupus erythematosus: How many patients and how to identify? [PDF]

Arch Rheumatol, 2022
Li H, Zheng Y, Chen L, Lin S.
europepmc   +1 more source

Regorafenib Induced Interstitial Pneumonia in a Patient With Refractory Rectal Cancer

Respirology Case Reports, Volume 13, Issue 8, August 2025.
We present a case involving a 66‐year‐old male patient with refractory colorectal cancer who developed interstitial pneumonia as a consequence of regorafenib therapy. This case illustrates a relatively rapid progression of regorafenib‐induced interstitial lung disease following its radiographic manifestation.
Tomo Tsunoda, Yoshiyuki Oyama, Ryota Miyamoto, Taisuke Ito, Takuro Akashi, Kazuo Tsuchiya, Masaki Ikeda   +6 more
wiley   +1 more source

The Immunodiagnostic Utility of Antinuclear Antibody Patterns: A Prediction for Renal Involvement in Systemic Lupus Erythematosus Patients in the Western Region of Saudi Arabia. [PDF]

Cureus, 2023
Al-Mughales J.
europepmc   +1 more source

Development of the Antinuclear and Anticytoplasmic Antibody Consensus Panel by the Association of Medical Laboratory Immunologists

, 2000
Karen James, A. Betts Carpenter, Linda S. Cook, R. Marchand, Robert M. Nakamura   +4 more
openalex   +1 more source

Arthritis in Cystic Fibrosis—Comparison of a Single‐Center Cohort and Published Case Reports/Series and a Review of the Literature

APMIS, Volume 133, Issue 8, August 2025.
ABSTRACT Cystic fibrosis (CF) is commonly associated with musculoskeletal issues including inflammatory arthritis, CF arthritis. We present a retrospective cohort study which aims to describe the clinical characteristics, prevalence, and demographic associations of CF arthritis using both a clinical and literature cohort.
Anne Sofie Rosenborg Peretz, Thomas Bryrup, Daniel Faurholt‐Jepsen, Christoffer Tandrup Holst Nielsen   +3 more
wiley   +1 more source

Screening for autoimmune diseases in apparently healthy antinuclear antibody positive individuals. [PDF]

Front Med (Lausanne)
Andraos R, Ahmad A, Wirestam L, Dahle C, Frodlund M, Rönnelid J, Kastbom A, Sjöwall C.   +7 more
europepmc   +1 more source

Serum vitamin D and antinuclear antibody level in oral lichen planus patients: a cross-sectional study. [PDF]

Ann Med Surg (Lond), 2023
Nosratzehi T.
europepmc   +1 more source

Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus [PDF]

, 2004
Ilse Hoffman
openalex   +1 more source

Artemisinins in autoimmune diseases: effects and mechanisms in systemic lupus erythematosus and rheumatoid arthritis

British Journal of Pharmacology, Volume 182, Issue 15, Page 3411-3427, August 2025.
Abstract Autoimmune diseases such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) result from immune self‐tolerance loss, causing tissue damage. Standard treatments targeting late‐stage inflammation often have serious side effects. Artemisinin, known for its antimalarial properties, shows potential immunomodulatory effects.
Fanchao Zhou, Guoming Li, Ruixiang Tan, Guodong Wu, Changsheng Deng   +4 more
wiley   +1 more source